• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者以进行性肺纤维化间质性肺病为表现,同时合并肺结节病和类风湿关节炎,接受尼达尼布治疗:病例报告和文献复习。

Pulmonary sarcoidosis complicated by rheumatoid arthritis in a patient presenting with progressive fibrosing interstitial lung disease and treated with nintedanib: a case report and literature review.

机构信息

Department of Pulmonary Medicine, Nippon Medical School Musashikosugi Hospital, Kawasaki-shi, Japan.

Department of Pulmonary Medicine, Nippon Medical School Musashikosugi Hospital, 1-383 Kosugi-machi, Nakahara-ku, Kawasaki-shi 211-8533, Japan.

出版信息

Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231158279. doi: 10.1177/17534666231158279.

DOI:10.1177/17534666231158279
PMID:36872912
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9989416/
Abstract

Sarcoidosis is a multisystem disease with an unknown etiology and is characterized by the formation of noncaseating granulomas in the affected organs. We present the case of a 69-year-old male Japanese patient with bilateral hilar lymphadenopathy on chest radiographs for more than 10 years, left without further investigation. The patient reported no clinical symptoms. Chest computed tomography revealed ground-glass opacities and reticular shadows in both lungs, along with bilateral hilar and mediastinal lymphadenopathy. Lymphocytosis was observed in bronchoalveolar lavage fluid. Pathological examination of transbronchial lung biopsy revealed noncaseating, epithelioid granulomas congruous with sarcoidosis, together with other findings. There were no abnormalities on electrocardiogram, echocardiogram, and ophthalmic examination.For progressive dyspnea on exertion, systemic corticosteroid therapy with oral prednisolone (25 mg/day) was initiated in 2017 and gradually tapered. Despite this intervention, the decline in forced vital capacity (FVC) was accelerated. Three years later, the patient noticed swelling in his right wrist. Further investigation revealed elevated anti-cyclic citrullinated peptide antibodies and absence of noncaseating epithelioid granuloma on surgical biopsy, leading to the diagnosis of rheumatoid arthritis (RA). Thereafter, the anti-fibrotic agent nintedanib was initiated, because interstitial lung disease (ILD) was considered to have converted into a progressive fibrosing phenotype (PF-ILD) with overlapping RA-associated lung involvement. With treatment, the progression of decline in FVC was slowed, although home oxygen therapy was introduced.

摘要

结节病是一种病因不明的多系统疾病,其特征是受累器官形成非干酪样肉芽肿。我们报告了一例 69 岁的日本男性患者,其胸部 X 线片显示双侧肺门淋巴结肿大超过 10 年,左侧未进一步检查。患者无临床症状。胸部计算机断层扫描显示双肺磨玻璃影和网状影,伴双侧肺门和纵隔淋巴结肿大。支气管肺泡灌洗液中淋巴细胞增多。经支气管肺活检的病理检查显示非干酪样、上皮样肉芽肿与结节病一致,同时还存在其他发现。心电图、超声心动图和眼科检查均无异常。由于进行性活动后呼吸困难,2017 年开始给予全身皮质类固醇治疗,口服泼尼松(25mg/天),并逐渐减量。尽管进行了干预,但用力肺活量(FVC)的下降加速。三年后,患者注意到右手腕肿胀。进一步检查显示抗环瓜氨酸肽抗体升高,手术活检未见非干酪样上皮样肉芽肿,诊断为类风湿关节炎(RA)。此后,开始使用抗纤维化药物尼达尼布,因为间质性肺病(ILD)被认为已转化为具有重叠 RA 相关肺受累的进行性纤维化表型(PF-ILD)。尽管开始了治疗,但 FVC 下降的进展仍有所减缓,尽管引入了家庭氧疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e49a/9989416/477cee93de24/10.1177_17534666231158279-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e49a/9989416/9389e825793e/10.1177_17534666231158279-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e49a/9989416/b599c7f2705b/10.1177_17534666231158279-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e49a/9989416/51c98daf0a4d/10.1177_17534666231158279-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e49a/9989416/477cee93de24/10.1177_17534666231158279-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e49a/9989416/9389e825793e/10.1177_17534666231158279-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e49a/9989416/b599c7f2705b/10.1177_17534666231158279-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e49a/9989416/51c98daf0a4d/10.1177_17534666231158279-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e49a/9989416/477cee93de24/10.1177_17534666231158279-fig4.jpg

相似文献

1
Pulmonary sarcoidosis complicated by rheumatoid arthritis in a patient presenting with progressive fibrosing interstitial lung disease and treated with nintedanib: a case report and literature review.患者以进行性肺纤维化间质性肺病为表现,同时合并肺结节病和类风湿关节炎,接受尼达尼布治疗:病例报告和文献复习。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231158279. doi: 10.1177/17534666231158279.
2
Current perspective of progressive-fibrosing interstitial lung disease.特发性肺纤维化的研究现状。
Respir Investig. 2022 Jul;60(4):503-509. doi: 10.1016/j.resinv.2022.03.004. Epub 2022 Apr 15.
3
Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.进行性纤维性间质性肺疾病:尼达尼布的新概念和适应证。
Mod Rheumatol. 2021 Jan;31(1):13-19. doi: 10.1080/14397595.2020.1826665.
4
Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial.尼达尼布治疗与类风湿关节炎相关的进行性肺纤维化患者的效果:来自 INBUILD 试验的数据。
Clin Rheumatol. 2023 Sep;42(9):2311-2319. doi: 10.1007/s10067-023-06623-7. Epub 2023 May 20.
5
Systemic Sarcoidosis Associated with Certolizumab Pegol Treatment for Rheumatoid Arthritis: A Case Report and Review of the Literature.与培塞利珠单抗治疗类风湿关节炎相关的系统性结节病:一例报告及文献复习
Intern Med. 2020 Aug 15;59(16):2015-2021. doi: 10.2169/internalmedicine.4275-19. Epub 2020 May 8.
6
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study.类风湿关节炎中的纤维化进行性间质性肺疾病:一项意大利多中心研究。
J Clin Med. 2023 Nov 11;12(22):7041. doi: 10.3390/jcm12227041.
7
Clinical relevance of rheumatoid factor and anti-citrullinated peptides in fibrotic interstitial lung disease.类风湿因子和抗瓜氨酸化肽在纤维化性间质性肺疾病中的临床意义。
Respirology. 2022 Oct;27(10):854-862. doi: 10.1111/resp.14301. Epub 2022 Jun 2.
8
Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers.进行性纤维性间质性肺病:在两个意大利转诊中心的患病率和特征。
Respiration. 2020;99(10):838-845. doi: 10.1159/000509556. Epub 2020 Dec 2.
9
Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis.在晚期肺结节病患者中 PF-ILD 表型的特征。
Respir Res. 2022 Jun 25;23(1):169. doi: 10.1186/s12931-022-02094-7.
10
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.尼达尼布治疗进行性肺纤维化间质性肺疾病患者- INBUILD 试验中按间质性肺疾病诊断的亚组分析:一项随机、双盲、安慰剂对照、平行组试验。
Lancet Respir Med. 2020 May;8(5):453-460. doi: 10.1016/S2213-2600(20)30036-9. Epub 2020 Mar 5.

本文引用的文献

1
Acute and Chronic Sarcoid Arthropathies: Characteristics and Treatments From a Retrospective Nationwide French Study.急性和慢性结节病性关节病:一项法国全国性回顾性研究的特征与治疗方法
Front Med (Lausanne). 2020 Dec 10;7:565420. doi: 10.3389/fmed.2020.565420. eCollection 2020.
2
Spectrum of Fibrotic Lung Diseases.纤维化性肺疾病谱
N Engl J Med. 2020 Sep 3;383(10):958-968. doi: 10.1056/NEJMra2005230.
3
Progressive fibrosing interstitial lung disease: treatable traits and therapeutic strategies.进行性纤维性间质性肺病:可治疗特征和治疗策略。
Curr Opin Pulm Med. 2020 Sep;26(5):436-442. doi: 10.1097/MCP.0000000000000712.
4
Cutaneous Sarcoidosis.皮肤结节病。
Semin Respir Crit Care Med. 2020 Oct;41(5):689-699. doi: 10.1055/s-0040-1713130. Epub 2020 Jun 27.
5
Systemic Sarcoidosis Associated with Certolizumab Pegol Treatment for Rheumatoid Arthritis: A Case Report and Review of the Literature.与培塞利珠单抗治疗类风湿关节炎相关的系统性结节病:一例报告及文献复习
Intern Med. 2020 Aug 15;59(16):2015-2021. doi: 10.2169/internalmedicine.4275-19. Epub 2020 May 8.
6
Honeycomb lung-like structures resulting from clustering of traction bronchiectasis distally in sarcoidosis.结节病中远端牵引性支气管扩张聚集形成的蜂窝肺样结构。
Respirol Case Rep. 2020 Mar 8;8(3):e00539. doi: 10.1002/rcr2.539. eCollection 2020 Apr.
7
Diagnosis issues in sarcoidosis.结节病的诊断问题。
Respir Med Res. 2020 Mar;77:37-45. doi: 10.1016/j.resmer.2019.09.002. Epub 2019 Oct 28.
8
Sarcoidosis presenting with and without Löfgren's syndrome: Clinical, radiological and behavioral differences observed in a group of 691patients.结节病伴或不伴 Löfgren 综合征:691 例患者的临床、放射学和行为差异观察。
Joint Bone Spine. 2020 Mar;87(2):141-147. doi: 10.1016/j.jbspin.2019.10.001. Epub 2019 Oct 11.
9
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.尼达尼布治疗进行性纤维化间质性肺疾病。
N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29.
10
Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management.进行性纤维性间质性肺疾病:诊断与管理的现行实践。
Curr Med Res Opin. 2019 Nov;35(11):2015-2024. doi: 10.1080/03007995.2019.1647040. Epub 2019 Aug 2.